Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
active comparator
Description:
An existing treatment used as a comparison group in clinical trials and pharmacoepidemiological studies of another treatment.
Related topics:
Statistical Methods in Clinical Trials (16%),
Diabetes Treatment and Management (9%),
Pharmacovigilance and Adverse Drug Reactions (8%)
OpenAlex ID:
keywords/active-comparator
Trials to assess equivalence: the importance of rigorous methods: Fig 1
1996
·
B Jones
, P Jarvis
, et al.
·
BMJ
·
1,084
Symptom Reduction and Suicide Risk in Patients Treated With Placebo in Antidepressant Clinical Trials: An Analysis of the Food and Drug Administration Database
2000
·
Arif Khan
, Heather A. Warner
, et al.
·
Archives of General Psychiatry
·
549
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
2010
·
S. Kunwar
, S. Chang
, et al.
·
Neuro-Oncology
·
519
PDF
Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial
2013
·
Michael Roden
, Jianping Weng
, et al.
·
The Lancet Diabetes & Endocrinology
·
512
Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials
2014
·
Benjamin Carlisle
, Jonathan Kimmelman
, et al.
·
Clinical Trials
·
413
Core concepts in pharmacoepidemiology: Confounding by indication and the role of active comparators
2022
·
Rachel Sendor
, Til Stürmer
·
Pharmacoepidemiology and Drug Safety
·
271
Misclassification in Administrative Claims Data: Quantifying the Impact on Treatment Effect Estimates
2014
·
Michele Jonsson Funk
, Suzanne N. Landi
·
Current Epidemiology Reports
·
253
PDF
Defining the noninferiority margin and analysing noninferiority: An overview
2017
·
Turki A. Althunian
, Anthonius de Boer
, et al.
·
British Journal of Clinical Pharmacology
·
246
PDF
A Combination of Riboflavin, Magnesium, and Feverfew for Migraine Prophylaxis: A Randomized Trial
2004
·
Morris Maizels
, Andrew Blumenfeld
, et al.
·
Headache The Journal of Head and Face Pain
·
190
Postapproval studies of drugs initially approved by the FDA on the basis of limited evidence: systematic review
2017
·
Alison M Pease
, Harlan M Krumholz
, et al.
·
BMJ
·
136
PDF
Methodological considerations when analysing and interpreting real-world data
2019
·
Til Stürmer
, Tiansheng Wang
, et al.
·
Rheumatology
·
116
Considerations for Pharmacoepidemiological Studies of Drug–Cancer Associations
2018
·
Anton Pottegård
, Søren Friis
, et al.
·
Basic & Clinical Pharmacology & Toxicology
·
111
PDF
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis
2022
·
Viktor Molander
, Hannah Bower
, et al.
·
Annals of the Rheumatic Diseases
·
109
PDF
Interventions for self-harm in children and adolescents
2020
·
Katrina G Witt
, Keith Hawton
, et al.
·
Cochrane Database of Systematic Reviews
·
102
Generating comparative evidence on new drugs and devices after approval
2020
·
Andrea Cipriani
, John P A Ioannidis
, et al.
·
The Lancet
·
102
Orphan drug development is progressing too slowly
2006
·
Roberta Joppi
, Vittorio Bertele
, et al.
·
British Journal of Clinical Pharmacology
·
85
PDF
Lithium therapy and weight change in people with bipolar disorder: A systematic review and meta-analysis
2021
·
Susana Gomes-da-Costa
, Wolfgang Marx
, et al.
·
Neuroscience & Biobehavioral Reviews
·
81
PDF
Psychosocial interventions for self-harm in adults
2020
·
Katrina G Witt
, Keith Hawton
, et al.
·
Cochrane Database of Systematic Reviews
·
78
PDF
The importance and implications of comparator selection in pharmacoepidemiologic research
2018
·
Monica D’Arcy
, Til Stürmer
, et al.
·
Current Epidemiology Reports
·
68
Bio‐creep in non‐inferiority clinical trials
2010
·
Siobhan Everson‐Stewart
, Scott S. Emerson
·
Statistics in Medicine
·
66
PDF
Considerations on the use of different comparators in pharmacovigilance: A methodological review
2023
·
Christopher A. Gravel
, Antonios Douros
·
British Journal of Clinical Pharmacology
·
65
PDF
Building Synergy between Regulatory and HTA Agencies beyond Processes and Procedures—Can We Effectively Align the Evidentiary Requirements? A Survey of Stakeholder Perceptions
2017
·
Ting Wang
, Neil McAuslane
, et al.
·
Value in Health
·
64
PDF
Haloperidol Dose When Used as Active Comparator in Randomized Controlled Trials With Atypical Antipsychotics in Schizophrenia: Comparison With Officially Recommended Doses
2006
·
Gerard W. K. Hugenholtz
, Eibert R. Heerdink
, et al.
·
The Journal of Clinical Psychiatry
·
59
Characteristics of efficacy evidence supporting approval of supplemental indications for prescription drugs in United States, 2005-14: systematic review
2015
·
Bo Wang
, Aaron S Kesselheim
·
BMJ
·
51
PDF
Control Conditions in Randomized Trials of Psychedelics: An ACTTION Systematic Review
2023
·
Sandeep M. Nayak
, Melissa K. Bradley
, et al.
·
The Journal of Clinical Psychiatry
·
49
Show more works
View as search
Works count:
263
Citation count:
6,483
Year
Topic
Type